Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quantum Cyber NVFRA:4TO 39 PS Ratio is 69.57 as of Jul. 14, 2026, which is 260% above its 10-year median of 19.32. GuruFocus rates FRA:4TO with a GF Score™ of 39/100 and a GF Value™ of €3.56. The stock has 9 warning signs investors should review. Among 201 Medical Diagnostics & Research companies, Quantum Cyber NV ranks worse than 82.09% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Quantum Cyber NV's share price is €8.00.
Quantum Cyber NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.12. Hence, Quantum Cyber NV's PS Ratio for today is 69.57.
The historical rank and industry rank for Quantum Cyber NV's PS Ratio or its related term are showing as below:
FRA:4TO'
s PS Ratio Range Over the Past 10 Years
Min: 1.1 Med: 19.32 Max: 346.35
Current: 9.47
During the past 7 years, Quantum Cyber NV's highest PS Ratio was 346.35. The lowest was 1.10. And the median was 19.32.
FRA:4TO's PS Ratio is ranked worse than 82.09% of 201
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.81
vs FRA:4TO: 9.47
Quantum Cyber NV revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Quantum Cyber NV was -90.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -60.80% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -40.30% per year.
During the past 7 years, Quantum Cyber NV's highest 3-Year average Revenue per Share Growth Rate was 16.00% per year. The lowest was -60.80% per year. And the median was -12.55% per year.
Back to Basics: PS Ratio
Quantum Cyber NV (FRA:4TO) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Quantum Cyber NV PS Ratio Related Terms
Quantum Cyber NV PS Ratio Historical Data
* Premium members only.
The historical data trend for Quantum Cyber NV's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Quantum Cyber NV's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quantum Cyber NV PS Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Quantum Cyber NV's PS Ratio distribution charts can be found below:
* The bar in red indicates where Quantum Cyber NV's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Quantum Cyber NV's Share Price of today is €8.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Quantum Cyber NV's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Quantum Cyber NV (FRA:4TO) has a PS Ratio of 69.57 as of Jul. 14, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Quantum Cyber NV and its competitors. This is 260% above median its historical median of 19.32. Over the past decade, Quantum Cyber NV's PS Ratio has ranged from 1.10 to 346.35. According to the industry distribution chart, Quantum Cyber NV ranks #165 out of 201 companies in the Medical Diagnostics & Research industry, placing it in the top 82.1%.
Is Quantum Cyber NV's PS Ratio too high?
Quantum Cyber NV's current PS Ratio of 69.57 is 260% above median its 10-year median of 19.32. Over the past 10 years, this metric has ranged from a low of 1.10 to a high of 346.35. The Medical Diagnostics & Research industry median PS Ratio is 2.81. Quantum Cyber NV's value of 69.57 is 2375.8% above this industry median. Based on the distribution chart, Quantum Cyber NV ranks #165 out of 201 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Quantum Cyber NV has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Quantum Cyber NV's PS Ratio compare to PRPO and BIOQ?
According to the Medical Diagnostics & Research industry distribution chart, Quantum Cyber NV ranks #165 out of 201 companies for PS Ratio. This places Quantum Cyber NV in the lower half of its industry. The industry median PS Ratio is 2.81. Quantum Cyber NV's value of 69.57 is 2375.8% above this benchmark. Historically, Quantum Cyber NV's own PS Ratio has ranged from 1.10 to 346.35 over the past decade. While the company's 10-year median is 19.32 vs. the industry median of 2.81, Quantum Cyber NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Diagnostics & Research company?
The median PS Ratio among Medical Diagnostics & Research companies is 2.81, based on 201 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quantum Cyber NV's current PS Ratio of 69.57 is 2375.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Quantum Cyber NV and its competitors. For the Medical Diagnostics & Research industry, the median PS Ratio is 2.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quantum Cyber NV's current PS Ratio is 69.57, which is 260% above median its own 10-year median of 19.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum Cyber NV stock overvalued right now?
Quantum Cyber NV (FRA:4TO) has a current PS Ratio of 69.57. The stock's GF Value™ is €3.56, compared to a current price of €8.00 — trading 124.7% above its estimated fair value. The current PS Ratio is 69.57, which is 260% above median its 10-year median of 19.32 and 2375.8% above the Medical Diagnostics & Research industry median of 2.81. Quantum Cyber NV's overall GF Score™ is 39/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Quantum Cyber NV (FRA:4TO), the current PS Ratio is 69.57 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Quantum Cyber NV (FRA:4TO) Overvalued in 2026?
Based on GuruFocus' analysis, Quantum Cyber NV stock appears to be overvalued.
The current stock price of €8.00 is trading 124.7% above its estimated GF Value™ of €3.56.
Key valuation signals for FRA:4TO:
PS Ratio: 69.57 (260% above median its 10-year median of 19.32)
GF Value™: €3.56 vs. price of €8.00 (124.7% above fair value)
Industry Position: 2375.8% above the Medical Diagnostics & Research median (#165 of 201)
No single metric tells the full story. See the FRA:4TO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.
39GF Score
Get the complete analysis for FRA:4TO
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4TO has been successfully added to your 
